Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

102.40p
   
  • Change Today:
      2.60p
  • 52 Week High: 110.00
  • 52 Week Low: 73.50
  • Currency: UK Pounds
  • Shares Issued: 536.76m
  • Volume: 384,610
  • Market Cap: £549.64m
  • RiskGrade: 119
  • Beta: 0.25

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth
15.94% above the market average15.94% above the market average15.94% above the market average15.94% above the market average15.94% above the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
1yr Revenue Growth
1.03% below the market average1.03% below the market average1.03% below the market average1.03% below the market average1.03% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield
39.2% below the market average39.2% below the market average39.2% below the market average39.2% below the market average39.2% below the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average
1yr DPS Growth
82.04% above the market average82.04% above the market average82.04% above the market average82.04% above the market average82.04% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
6.7% below the market average6.7% below the market average6.7% below the market average6.7% below the market average6.7% below the market average
46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average46.67% below the sector average
Price Book Ratio
14.11% below the market average14.11% below the market average14.11% below the market average14.11% below the market average14.11% below the market average
58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average58.33% above the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
19.2% below the market average19.2% below the market average19.2% below the market average19.2% below the market average19.2% below the market average
18.03% above the sector average18.03% above the sector average18.03% above the sector average18.03% above the sector average18.03% above the sector average
Price Chg 3m
25.8% below the market average25.8% below the market average25.8% below the market average25.8% below the market average25.8% below the market average
1.64% above the sector average1.64% above the sector average1.64% above the sector average1.64% above the sector average1.64% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
11.66% below the market average11.66% below the market average11.66% below the market average11.66% below the market average11.66% below the market average
5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average
Momentum 20
16.58% below the market average16.58% below the market average16.58% below the market average16.58% below the market average16.58% below the market average
5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average5.08% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
25.13% above the market average25.13% above the market average25.13% above the market average25.13% above the market average25.13% above the market average
41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average41.18% above the sector average
ROCE
51.71% above the market average51.71% above the market average51.71% above the market average51.71% above the market average51.71% above the market average
11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average11.11% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
23.67% above the market average23.67% above the market average23.67% above the market average23.67% above the market average23.67% above the market average
45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average45.83% above the sector average
Forecast EPS
52.63% below the market average52.63% below the market average52.63% below the market average52.63% below the market average52.63% below the market average
62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average62.5% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
38.95% above the market average38.95% above the market average38.95% above the market average38.95% above the market average38.95% above the market average
58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average58.82% above the sector average
Operating Profit Loss
50.69% above the market average50.69% above the market average50.69% above the market average50.69% above the market average50.69% above the market average
72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average72.00% above the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
35.31% above the market average35.31% above the market average35.31% above the market average35.31% above the market average35.31% above the market average
53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average53.19% above the sector average
Cash
35.77% above the market average35.77% above the market average35.77% above the market average35.77% above the market average35.77% above the market average
44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average44.00% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
3.61% below the market average3.61% below the market average3.61% below the market average3.61% below the market average3.61% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Buys 1y
56.69% above the market average56.69% above the market average56.69% above the market average56.69% above the market average56.69% above the market average
67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average67.44% above the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
81.72% above the market average81.72% above the market average81.72% above the market average81.72% above the market average81.72% above the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 102.40p
Change Today 2.60p
% Change 2.61 %
52 Week High 110.00
52 Week Low 73.50
Volume 384,610
Shares Issued 536.76m
Market Cap £549.64m
Beta 0.25
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
86.21% below the market average86.21% below the market average86.21% below the market average86.21% below the market average86.21% below the market average
16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average16.00% above the sector average
Price Trend
53.93% above the market average53.93% above the market average53.93% above the market average53.93% above the market average53.93% above the market average
27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average27.87% above the sector average
Income
50% below the market average50% below the market average50% below the market average50% below the market average50% below the market average
9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average9.09% above the sector average
Growth
12.68% below the market average12.68% below the market average12.68% below the market average12.68% below the market average12.68% below the market average
94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average94.29% below the sector average

What The Brokers Say

Strong Buy 3
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 3
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Interim Final
Ex-Div 16-Dec-21 10-Jun-21
Paid 07-Jan-22 08-Jul-21
Amount 0.56p 1.07p

Trades for 30-Nov-2021

Time Volume / Share Price
15:57 1,458 @ 102.40p
15:57 880 @ 102.40p
15:57 1,433 @ 102.40p
15:54 480 @ 102.40p
15:54 335 @ 102.40p

Alliance Pharma Key Personnel

CEO Peter Butterfield
CFO Andrew Franklin

Top of Page